Literature DB >> 6970198

In vivo rates of pyrimidine nucleotide metabolism in intact mouse T-lymphoma (s-49) cells treated with 5-fluorouracil.

J Maybaum, M B Cohen, W Sadee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970198

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  Variation of mutation and recombination frequencies over a range of thymidylate concentrations in a diploid thymidylate auxotroph.

Authors:  F Eckardt; B A Kunz; R H Haynes
Journal:  Curr Genet       Date:  1983-09       Impact factor: 3.886

2.  Compartmentation of guanine nucleotide precursors for DNA synthesis.

Authors:  B T Nguyen; W Sadée
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.

Authors:  D S Duan; T Nagashima; T Hoshino; F Waldman; K Pawlak; W Sadee
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

4.  Guanine for DNA synthesis. A compulsory route through ribonucleotide reductase.

Authors:  D S Duan; W Sadee
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

Review 5.  Clinical and preclinical pharmacokinetics of raltitrexed.

Authors:  S J Clarke; P J Beale; L P Rivory
Journal:  Clin Pharmacokinet       Date:  2000-12       Impact factor: 6.447

Review 6.  Tomudex (ZD1694): from concept to care, a programme in rational drug discovery.

Authors:  A L Jackman; F T Boyle; K R Harrap
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

7.  Cell cycle-dependent effects on deoxyribonucleotide and DNA labeling by nucleoside precursors in mammalian cells.

Authors:  J M Leeds; C K Mathews
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.

Authors:  K M Li; L P Rivory; S J Clarke
Journal:  Br J Cancer       Date:  2007-10-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.